News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|September 27, 2017

Educational Resources and Patient Support

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
Bladder.

Bladder Adenocarcinoma: An Overview for the Newly Diagnosed

ByAlex Biese
December 13th 2025
bladder cancer

TARA-002 Shows Potential in BCG-Naive NMIBC Treatment

ByRyan Scott
December 5th 2025
Image of bladder.

Basics of Squamous Cell Bladder Cancer

ByAlex Biese
November 25th 2025
FDA sign image

AVZO-103 Wins FDA Designation for Previously Treated Urothelial Cancer

ByRyan Scott
November 25th 2025
Image of "FDA"

FDA Approves Keytruda and Padcev for Muscle Invasive Bladder Cancer

BySpencer Feldman
November 21st 2025
Advertisement
Advertisement

Trending on CURE

1

FDA Approves Enhertu Plus Perjeta in Advanced HER2+ Breast Cancer

2

FDA Grants Breakthrough Designation to INCA-33989 in Essential Thrombocythemia

3

SHARON Trial Offers a Potential Approach for Advanced Pancreatic Cancer

4

Cancer in the Rearview Mirror

5

FDA Grants Fast Track Status to Muzastotug for Some Colorectal Cancers

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.